Netherlands vs Slovakia: The number of people with susceptibility test result for rifampicin
Netherlands
86.26
in 2021
Slovakia
84.42
in 2021
Netherlands rank
82nd
Slovakia rank
85th
The number of people with susceptibility test result for rifampicin over time
- Netherlands
- Slovakia
How they compare
Netherlands currently reports 86.26 against 84.42 in Slovakia, a difference of 1.84.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Netherlands ahead.
Netherlands ranks 82nd and Slovakia ranks 85th of 146 countries.
Netherlands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Netherlands | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 88.98 | 82.32 | 6.66 | Netherlands |
| 2020s | 86.86 | 82.68 | 4.17 | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Netherlands or Slovakia?
- Netherlands, at 86.26 against 84.42 in Slovakia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Netherlands and Slovakia?
- 1.84, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Slovakia?
- 5 years are reported by both, from 2017 to 2021.
- How do Netherlands and Slovakia rank globally for the number of people with susceptibility test result for rifampicin?
- Netherlands ranks 82nd and Slovakia ranks 85th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.